This trial is active, not recruiting.

Condition antepartum hemorrhage
Treatment masimo radical-7™ pulse co-oximeter
Sponsor Kasr El Aini Hospital
Start date March 2015
End date November 2015
Trial size 124 participants
Trial identifier NCT02614053, mp3


The purpose of this study is to evaluate the use of continuous noninvasive intraoperative plethesmography variability index in conjunction with Hemoglobin levels monitoring using Masimo Radical-7™ Pulse CO-Oximeter during elective cesarean sections in patients with antepartum and intrapartum hemorrhage as a guide for fluid and blood transfusion practice .

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

Pleth Variability Index
time frame: throughout the operation

Secondary Outcomes

hemoglobin level
time frame: throughout the operation

Eligibility Criteria

Female participants from 18 years up to 40 years old.

Inclusion Criteria: - Anesthesiologist (ASA) Physical status I - II. - patients aged from 18 to 40 years - full-term multigravida parturients - antepartum hemorrhage - singleton fetus Exclusion Criteria: - Patients with known cardiac problem - peripheral circulatory failure of the upper extremities - significant liver disease - significant renal disease - significant coagulopathy

Additional Information

Official title Continuous Non Invasive Monitoring of Both Plethysmography Variability Index and Total Hemoglobin During Cesarean Section for Antepartum Hemorrhage As a Method For Early Detection of Bleeding
Trial information was received from ClinicalTrials.gov and was last updated in November 2015.
Information provided to ClinicalTrials.gov by Kasr El Aini Hospital.